ASCO Guidelines

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

Release Date

All Episodes

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline 2026.1.0

Dr. Jennifer Caswell-Jin and Dr. Michael Hassett join the podcast to introduce the new living guideline, "Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer." As co-chairs of the expert panel, they provide a comprehensive overview of the guidel ... Show more

. 14min 19sec

Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on ... Show more

. 19min 32sec

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline 2026.1.0

Drs. Jamie Lesnock and Sara Bouberhan join the podcast to discuss the first ASCO guideline on systemic treatment for recurrent ovarian cancer. They provide a comprehensive overview of the evidence-based recommendations for patients with both platinum-sensitive and platinum-resist ... Show more

. 21min 26sec

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2

Dr. Sonam Puri joins the podcast to share the update to the living guideline on stage IV NSCLC with driver alterations. Dr. Puri discusses the practice-changing evidence reviewed for both NTRK rearrangements, including the TRIDENT-1 trial, and HER2 activating mutations, including ... Show more

. 9min 0sec